DOCSLIB.ORG

Phd-Brandrud-2019.Pdf

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Phd-Brandrud-2019.Pdf ,(#(!)/..")(#.#)(- ),#'*,)0'(.( 2&&(., ,)'"#!"*, ),'#(!&#(#&(.1),%- /&.3) ##( DBCK ,(#(!)/..")(#.#)(- ),#'*,)0'(.( 2&&(., ,)'"#!"*, ),'#(!&#(#&(.1),%- 0%+$+9/8$82$8;$ *%9+9(38:*%$%)8%%3(*+03936*+%3#:38R*S ::*%2+=%89+:@3(903 a_`g J.'#-#(-% %/&.. >&##-%,,(,/DBCK "0&"1,#!&11"022&,+113*&22"!2,2%" 3)27,#"!& &+";+&4"01&27,#1), 008+)*:8%9%8=%$K368:3(:*+96;"0+#:+321@"% 8%683$;#%$38:8291+::%$H+22@(38138"@2@1%29H>+:*3;:6%81+99+32K 3=%8J;$ .%8;0$9%2;))%a_`bH $%02$)099=%8/J8:3(%138+0:5@=+#:+19 %683$;#%$>+:*6%81+99+32 8+2:683$;#:+32J There is a crack in everything. That’s where the light gets in. (:%8`d=%8@+2:%8%9:+2)@%8992;89%2%9:*%:+9:H 9:8:%$1@7;0+:@+1683=%1%2:.3;82%@+2 `hh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`hhgH *=%"%%2+2=30=%$+2:*%+1683=%1%2:$=+938:%13(:*%0%82+2)#300"38:+=%93( :*%38>%)+2%$+#0993#+:+32RSK :*9"%%28%>8$+2)%((38:K*%$+8%#:38(38683(%99+320 #316%:%2#%H 299".582 301H+2+:+:%$2$12)%$:*%#300"38:+=%9K 9 2 %?6%8+%2#%$ 6*@9+#+2H*%fully understood the importance of involving the clinicians in a knowledge based “bottom up” approach to quality improvementH)83;2$%$321;0:+683(%99+320#300"38:+32H1%9;8%1%2: 2$/23>0%$)%P"9%$+1683=%1%2:);+$2#%K 9:8:%$1@8%9%8#*.3;82%@+2a__d>+:*9;6638:(831 299".582H:*%;0+:@+1683=%1%2:(;2$ 3( :*% H 2$ (831 1@ 0%$%89 :. 8>+:A 2$ 22 %903 : +2)%8+/% *396+:0K *% .3;82%@ +2#0;$%$9:;$@3(:*%+2:%00%#:;0;2$%86+22+2)93(7;0+:@+1683=%1%2::8:13;:*+2a__f2$ a__gH::*%(33:3(:*%7;0+:@+1683=%1%2:)+2:9;0:0$%22$;)%2%%0932H2$;2$%8:*% >+2)93(8.38+% 3$(8%@K 1(38%=%8)8:%(;0:31@0%$%89(389;6638:+2)1@9:;$+%9K *=%1$%1@*P9:;$@;2$%8:*%"8=%2$9;6638:+=%0%$%89*+63( +0$%/8%$:=%+:3%2H2$ :*% $+8%#:38 (38 683(%99+320 #316%:%2#% +2 %9:8% +/%2 0($2 99K 2$389+2) 1@ 9:;$@H :*%@ 003>%$1%:3.3+2*683)81::*%#;0:@3(1%$+#+2%+H(38:*8%%@%892$2+2%132:*9+2 g_6%8#%2:3(1@639+:+3299%2+38$=+938::*%7;0+:@$%68:1%2:3(%9:8%+/%2 396+:08;9:K 38/+2)(38931%:*+2))8%:%8:*21%H *=%*$:*%60%9;8%:3+2=30=%:*%139:%?#%00%2: 8%68%9%2::+=%93(:*%2%?:)%2%8:+323(*%0:*#8%683(%99+3209+2:*%683#%99K :+9+168%99+=%:3 >+:2%99 :*%+8 %?#%00%2: %((38:9 +2 :*% $%=%0361%2: 3( 9;##%99(;0 %$;#:+320 683)819 "3;: :*% #32:+2;0 +1683=%1%2: 1%:*3$ 2$ 9/+009 :3 2 +2#8%9+2) 2;1"%8 3( 0%$%89H $=+9389 2$ +1683=%1%2::%19:%9:8%+/%22$3:*%8*396+:09+23;8*%0:*8%)+32H2$:39%=%8038>%)+2 ;2+=%89+:+%92$#300%)%)8$;:%9K :*2/ ;2% ;(:%H %8+: 8+% 0582%9H 22% ;8+:A%2H 09% 8%+2%9H 9:8+$ ;2$%9)8$H 32% *38%9%2H8)8%: #3"9%2H;$00%2 ;)%2H%2:%329%2H%::%0"%8)H%2$%8+)=%$H *8+9:+2%8+%@))H%8%:%+2.82H8+%8)0+H0+9"%:* 9H+)$+9#*%%1"H2$%8P8+/ 303H:*%1%1"%893((38;1H2$001@3:*%8#300%);%9(38@3;8#336%8:+322$/23>0%$)% 9*8+2)K 2$$+:+32H *=%*;2$8%$93(683(%99+3209:3:*2/(38>*: *=%0%82%$(831:*%+8#*2)%%((38:9K *=%"%%2>38/+2)2$0%82+2):3)%:*%8>+:*:*%19+2#% 0%(:1@639+:+3292;89%2%9:*%:+9:+2 `hha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n this thesis, “we” means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aa ;0@P9:;$@ >+:*=0;"0%2$"83$%?6%8+%2#%(831#8+9+912)%1%2:H69@#*393#+09;6638:2$:8;1#8% >+:*+29;8)%8@H2%9:*%9+303)@H+2:%8201%$+#+2%H69@#*+:8@H2$(1+0@1%$+#+2%K :+9+1638:2:(381%:3#311%138:%$3#:38 3*230+2330%(38*+9830%+2:*%;9:+2"+0+:@9:;$@ 3(:*%9;##%99(;003#01%$+#08%96329%(:%8:*%:5@:%8838::#/K+89:H30+2>9=0;"0%93;8#% 3(+2(381:+32"@*+9639+:+329$;0#3112$%8:*:$@9H2$:*%2*%>91%1"%83(:*% 8%9%8#*:%1;2:+0*%9;$$%20@$+%$+2%"8;8@a_`cH+2:*%3;2:+293(*132+?K aaK ;0@a_``H30+2>9:*%*+%(%$+#0((+#%83(:*%9;8)+#0$%68:1%2:3(+2)%8+/%2$!8;1 *396+:0K9#%8:+(+%$$=2#%$8;1+(%;6638:RS+29:8;#:38H*%>9$8+=+2)(38#%+2:*% $%=%0361%2:3(:*%03#0%1%8)%2#@1%$+#09%8=+#%K 2:*%0:%(:%823323(aa ;0@H*%=30;2:%%8%$ (831=#:+32H9=+2)0+=%92$68:+#+6:+2)+2:*%:#:+#00%$%89*+6:%1>+:**+9*+)*0@668%#+:%$ #316%:%2#%K >2::3:*2/:*%R(%>S(8+%2$92$(1+0@1%1"%89>*3*=%"%%26@+2)1@9:;$+%9+2:%8%9:H2$ 00:*%3:*%89(38*%06+2)1%%9#6%(831:*+932)3+2)H+2:%29+=%=%2:;8%"@9;6638:+2)1@830%9 (8+%2$H9+9:%8H;2:H#3;9+2H13:*%8H13:*%8+20>H2$2%?:8%1%0@*66@)82$13:*%8:3:%23(:*% 139:>32$%8(;0$30%9#%2:92$#*+0$8%2K +200@H :*2/1@*;9"2$2$"%9:(8+%2$8@)=%K*2/@3;(380>@9"%+2):*%8%(381%K*2/ @3;(3868:+#+6:+2)>+:*6:+%2#%+21@8%(0%#:+3293=%8:*%/+:#*%2:"0%$@3;:2$$@+200:*%9% @%89H683=+$+2)1%>+:*);+$2#%H>+9$312$/23>0%$)%"9%$32@3;83>2#$%1+#.3;82%@H2$ 32@3;812@@%8999%2+3812)%8+208)%38)2+A:+329>*%8%#329:2:#*2)%+9:*%23810K 6 !)-+=6.&&+",4%",-,'"'"-"(', >9>9&) )(.(.- 8KKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKK` "*.,C8/'',#-6&#-.-( #(#.#)(-KKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKK` `K`K"0%3(#32:%2:9KKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKK` `KaK;118@KKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKd `KbK*%9+99:8;#:;8%KKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKe `KcK8+)+2066%89KKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKf `KdK"0%9H+);8%92$3?%9KKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKg `KeK 03998@Z""8%=+:+329KKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKh `KfK 2$%?3(:*%9+?#32$+:+329(381/+2):*+2)9)38+)*:KKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKK`c 8 KKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKK`f "*.,D8,)&'-,#*.#)(KKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKK`f D8C8"3#1)."#-5KKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKK`f aK`K`K8@+2)*8$%8>+0023:>38/KKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKK`f aK`KaK*%=3+#%3(:*%*%0:*#8%683(%99+320KKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKK`g aK`KbK +)*6%8(381+2)*%0:*#8%9%8=+#%9KKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKK`h aK`KcK 2$+=+$;07;0+:@=%89;99@9:%17;0+:@KKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKK`h aK`KdK/+2)9%29%3(:*%38@2$+:9;9%+2+1683=%1%2:KKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKa` D8D8",-,"+/-.#)(-) ."."-#-KKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKaa D8E8&#(.#)() ."."-#-KKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKab "*.,E8..) %()1&!KKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKad
Load more

Recommended publications
  • Norwegian Journal of Epidemiology Årgang 27, Supplement 1, Oktober 2017 Utgitt Av Norsk Forening for Epidemiologi
    1 Norsk Epidemiologi Norwegian Journal of Epidemiology Årgang 27, supplement 1, oktober 2017 Utgitt av Norsk forening for epidemiologi Redaktør: Trond Peder Flaten EN NORSKE Institutt for kjemi, D 24. Norges teknisk-naturvitenskapelige universitet, 7491 Trondheim EPIDEMIOLOGIKONFERANSEN e-post: [email protected] For å bli medlem av Norsk forening for TROMSØ, epidemiologi (NOFE) eller abonnere, send e-post til NOFE: [email protected]. 7.-8. NOVEMBER 2017 Internettadresse for NOFE: http://www.nofe.no e-post: [email protected] WELCOME TO TROMSØ 2 ISSN 0803-4206 PROGRAM OVERVIEW 3 Opplag: 185 PROGRAM FOR PARALLEL SESSIONS 5 Trykk: NTNU Grafisk senter Layout og typografi: Redaktøren ABSTRACTS 9 Tidsskriftet er åpent tilgjengelig online: LIST OF PARTICIPANTS 86 www.www.ntnu.no/ojs/index.php/norepid Også via Directory of Open Access Journals (www.doaj.org) Utgis vanligvis med to regulære temanummer pr. år. I tillegg kommer supplement med sammendrag fra Norsk forening for epidemiologis årlige konferanse. 2 Norsk Epidemiologi 2017; 27 (Supplement 1) The 24th Norwegian Conference on Epidemiology Tromsø, November 7-8, 2017 We would like to welcome you to Tromsø and the 24th conference of the Norwegian Epidemiological Association (NOFE). The NOFE conference is an important meeting point for epidemiologists to exchange high quality research methods and findings, and together advance the broad research field of epidemiology. As in previous years, there are a diversity of topics; epidemiological methods, cardiovascular disease, diabetes, cancer, nutrition, female health, musculo-skeletal diseases, infection and behavioral epidemiology, all within the framework of this years’ conference theme; New frontiers in epidemiology. The conference theme reflects the mandate to pursue methodological and scientific progress and to be in the forefront of the epidemiological research field.
    [Show full text]
  • Oslo Government District Bombing and Utøya Island Shooting July 22, 2011: the Immediate Prehospital Emergency Medical Service Response Sollid Et Al
    Oslo government district bombing and Utøya island shooting July 22, 2011: The immediate prehospital emergency medical service response Sollid et al. Sollid et al. Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine 2012, 20:3 http://www.sjtrem.com/content/20/1/3 (17 January 2012) Sollid et al. Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine 2012, 20:3 http://www.sjtrem.com/content/20/1/3 ORIGINALRESEARCH Open Access Oslo government district bombing and Utøya island shooting July 22, 2011: The immediate prehospital emergency medical service response Stephen JM Sollid1,2,3*, Rune Rimstad4,5,6, Marius Rehn2, Anders R Nakstad1, Ann-Elin Tomlinson7, Terje Strand1, Hans Julius Heimdal1, Jan Erik Nilsen1,8 and Mårten Sandberg1,9, for Collaborating group Abstract Background: On July 22, 2011, a single perpetrator killed 77 people in a car bomb attack and a shooting spree incident in Norway. This article describes the emergency medical service (EMS) response elicited by the two incidents. Methods: A retrospective and observational study was conducted based on data from the EMS systems involved and the public domain. The study was approved by the Data Protection Official and was defined as a quality improvement project. Results: We describe the timeline and logistics of the EMS response, focusing on alarm, dispatch, initial response, triage and evacuation. The scenes in the Oslo government district and at Utøya island are described separately. Conclusions: Many EMS units were activated and effectively used despite the occurrence of two geographically separate incidents within a short time frame. Important lessons were learned regarding triage and evacuation, patient flow and communication, the use of and need for emergency equipment and the coordination of helicopter EMS.
    [Show full text]
  • Annual Report Research Activity 2019
    Annual Report Research Activity 2019 Division of Clinical Neuroscience University of Oslo and Oslo University Hospital 0 Contents Oslo University Hospital and the University of Oslo .................................................................................... 4 From Division Director Eva Bjørstad ........................................................................................................... 4 Division of Clinical Neuroscience (NVR) Organizational Chart ..................................................................... 5 Department of Physical Medicine and Rehabilitation Rehabilitation after trauma....................................................................................................................... 6 Group Leader: Nada Andelic Painful musculoskeletal disorders .............................................................................................................. 9 Group Leader: Cecilie Røe Department of Refractory Epilepsy - National Centre for Epilepsy Complex epilepsy .................................................................................................................................... 11 Group Leader: Morten Lossius Department of Neurosurgery Neurovascular-Hydrocephalus Research Group ..................................................................................... 16 Group Leader: Per Kristian Eide Oslo Neurosurgical Outcome Study Group (ONOSG) ................................................................................. 19 Group Leaders: Eirik Helseth and Torstein
    [Show full text]
  • Report from the Norwegian Board of Health Supervision 3/2014
    Serious Adverse Events in Hospitals Could this have happened here? Examples and experience gained from investigation of serious adverse events 2010–2013 REPORT OF THE NORWEGIAN BOARD OF HEALTH SUPERVISION 3/2014 MARCH 2014 Report of the Norwegian Board of Health Supervision 3/2014 Could this have happened here? Examples and experience gained from investigation of serious adverse events 2010–2013 Svikt i samhandling, kommunikasjon og kompetanse i alvorlige hendelser …… kunne det skjedd hos oss? Eksempler og erfaringer 2010–2013 fra Undersøkelsesenhetens arbeid med varsler om alvorlige hendelser i spesialisthelsetjenesten (§ 3-3a i spesialisthelsetjenesteloven) (Rapport fra Helsetilsynet 3/2014) Norwegian Board of Health Supervision, March 2014 ISSN: 1503­4798 (electronic version) ISBN: 978­82­90919­73­8 (electronic) ISBN: 978­82­90919­74­5 (print) The report is available on the Norwegian Board of Health Supervision’s website, www.helsetilsynet.no Design: Gazette Print and electronic version: 07 Media Norwegian Board of Health Supervision / Statens helsetilsyn P.O. Box 8128 Dep, NO­0032 OSLO, Norway Telephone: +47 21 52 99 00 E­mail: [email protected] Could this have happened here? Examples and experience gained from investigation of serious adverse events 2010–2013. Serious Adverse Events in Hospitals 2 REPORT OF THE NORWEGIAN BOARD OF HEALTH SUPERVISION/ 3/2014 Contents The director’s foreword .............................................................................................................. 5 A few notes on the report
    [Show full text]
  • Evaluation of Remdesivir and Hydroxychloroquine on Viral Clearance in Covid-19 Patients: Results from the NOR-Solidarity Randomised Trial
    Evaluation of remdesivir and hydroxychloroquine on viral clearance in Covid-19 patients: Results from the NOR-Solidarity Randomised Trial Andreas Barratt-Due1,2,9,*, Inge Christoffer Olsen3, Katerina Nezvalova Henriksen4,5, Trine Kåsine1,9, Fridtjof Lund-Johansen2,6, Hedda Hoel7,9,10, Aleksander Rygh Holten8,9, Anders Tveita11, Alexander Mathiessen12, Mette Haugli13, Ragnhild Eiken14, Anders Benjamin Kildal15, Åse Berg16, Asgeir Johannessen9,17, Lars Heggelund18,19, Tuva Børresdatter Dahl1,10, Karoline Hansen Skåra10, Pawel Mielnik20, Lan Ai Kieu Le21, Lars Thoresen22, Gernot Ernst23, Dag Arne Lihaug Hoff24, Hilde Skudal25, Bård Reiakvam Kittang26, Roy Bjørkholt Olsen27, Birgitte Tholin28, Carl Magnus Ystrøm29, Nina Vibeche Skei30, Trung Tran2, Susanne Dudman9,39, Jan Terje Andersen9,31, Raisa Hannula32, Olav Dalgard9,33, Ane-Kristine Finbråten7,34, Kristian Tonby9,35, Bjorn Blomberg36,37, Saad Aballi38, Cathrine Fladeby39, Anne Steffensen9, Fredrik Müller9,39, Anne Ma Dyrhol-Riise9,35, Marius Trøseid9,40 and Pål Aukrust9,10,40 on behalf of the NOR-Solidarity study group# 1Division of Critical Care and Emergencies, Oslo University Hospital, 0424 Oslo, Norway 2Division of laboratory Medicine, Dept. of Immunology, Oslo University Hospital, 0424 Oslo, Norway 3Department of Research Support for Clinical Trials, Oslo University Hospital, 0424 Oslo, Norway 4Department of Haematology, Oslo University Hospital, 0424 Oslo, Norway 5Hospital Pharmacies, South-Eastern Norway Enterprise, 0050 Oslo, Norway 6ImmunoLingo Covergence Centre, University
    [Show full text]
  • Annual Report Research Activity 2019
    Annual Report Research Activity 2019 Division of Orthopaedic Surgery University of Oslo, Diakonhjemmet Hospital and Oslo University Hospital 0 Content Research activity at the Division of Orthopaedic Surgery and Department of Rheumatology, Diakonhjemmet Hospital ............................................................................................................................... 2 Osteoarthritis Research Group ...................................................................................................................... 4 Group Leader: Lars Nordsletten Pediatric Orthopaedics .................................................................................................................................. 6 Group Leader: Joachim Horn Biomechanics Laboratory .............................................................................................................................. 9 Group Leader: Harald Steen Center for Implant and Radiostereometric Research Oslo – CIRRO ........................................................... 14 Group Leaders: Stephan Röhrl and Lars Nordsletten Hand ............................................................................................................................................................ 19 Group Leader: Magne Røkkum Norwegian research center for Active Rehabilitation – NAR ...................................................................... 22 Group Leader: May Arna Risberg Oncological Orthopedics ............................................................................................................................
    [Show full text]
  • Faculty of Medicine
    About the Faculty of Medicine, University of Oslo With approximately one third of all medical students in Norway and almost two thirds of all PhD candidates, the Faculty of Medicine at the University of Oslo (UiO) has an important responsi- bility for providing high standards of medical education and research. The Faculty also offers a wide range of research and studies within health-related topics such as health administration, international health and nutrition. Norway has a well developed public health care system, and our researchers co-operate with different governmental bodies to ensure and support high standards. FACULTY OF MEDICINE Founded in 1814, the Faculty of Medicine is one of eight faculties at UiO. With approximately PO BOX 1078 Blindern, 0316 Oslo, Norway 1500 employees, our most important tasks are education, research and dissemination of Sogn Arena, 2. etg, Klaus Torgårds vei 3 information. The faculty’s annual budget is approximately 1 billion NOK (162 million USD), out Tel: +47 22 84 53 10 - Fax: +47 22 84 53 01 of which more than 50% are generated through external funding. UiO Faculty of Medicine F FACTS AND FIGURES (2009) OTO : THE University of Oslo (founded 1811) A n 7 000 employees TØ n Yearly budget: appr. 5.5 billion NOK (900 million USD) NN E S n 28 000 students E N , O S Oslo University Hospital L O n 20 000 employees UN n Yearly budget: appr. 18 billion NOK (3 billion USD) IVER S n I More than 1.2 million patients treated each year T E tssyk Akershus University Hospital n 5 000 employees EH n US Yearly budget: appr.
    [Show full text]
  • Motivation Letter Oslo, May 27Th, 2021 Dear ESGO Colleagues, I Am Writing
    Motivation letter Oslo, May 27th, 2021 Dear ESGO colleagues, I am writing to express my great interest in running for ESGO council. As an active member of the society for many years, I have enjoyed taking part in various meetings and educational activities both in-person and online, benefiting from the hard work and dedication of the ESGO leadership. To be a part of this leadership team would be very rewarding and a great honor. I currently have the privilege of holding the position of social media editor for the International Journal of Gynecological Cancer. In this role I have worked closely with editor in chief, Pedro Ramirez, and learned a great deal from him regarding academic leadership. I have initiated a virtual journal club, mentored editorial fellows and been able to grow the journals social media followers on Twitter from ca 100 to more than 3000 in two years. Through this experience I have also very much enjoyed collaborating with the ESGO office, and my fellow associate editors from ESGO. As a gynecologic oncologist at the Norwegian Radiumhospital my main focus is surgical treatment of gynecologic malignancies, both robotic surgery and radical cytoreductive procedures. Since my return from fellowship at MSKCC in 2015 I have taken on the lead of our Endometrial cancer and gyn sarcoma team, have been responsible for organizing the annual Tropé meeting on updates and controversies in gynecologic oncology with professor emeritus Claes Tropé, and more recently initiated a course in ovarian cancer surgery, this year in conjunction with ESGO. Thank you for the opportunity to apply for ESGO council.
    [Show full text]
  • Method for Collection and Quality Assurance of Hip Fracture Data from Norwegian Hospitals 1994-2008
    The NOREPOS* Hip Fracture Database: Method for collection and quality assurance of hip fracture data from Norwegian hospitals 1994-2008 Tone K. Omsland 1,2 , Kristin Holvik 1,2 , Anne Johanne Søgaard 1,Haakon E. Meyer 1,3 Affiliation of authors: 1Division of Epidemiology, Norwegian Institute of Public Health, Oslo, Norway 2Department of Public Health and Primary Health Care, University of Bergen, Norway 3Institute of Health and Society, Department of Community Medicine, University of Oslo, Norway Corresponding author: Tone Kristin Omsland, Division of Epidemiology, Norwegian Institute of Public Health, PO Box 4704 Nydalen, N-0403 Oslo, Norway Telephone: 00 47 21 07 83 41 Fax number: 00 47 21 07 82 60 E-mail: [email protected] * NOREPOS (The NORwegian EPidemiologic Osteoporosis Studies) is a collaboration between epidemiologic osteoporosis studies, which are sub-studies within large population- based surveys in four districts of Norway (Tromsø, Nord-Trøndelag, Hordaland, Oslo). The NOREPOS Hip fracture Database includes all hospitalizations for hip fracture in Norway. 1 SUMMARY • During 2009-2011, NOREPOS (Norwegian Epidemiologic Osteoporosis Studies) established a database consisting of all hip fractures treated in Norwegian hospitals during the 15-year period 01.01.1994 - 31.12.2008. • Hip fracture data were retrieved by a system developed by the Norwegian Knowledge Centre for the Health Services, which was linked to the Patient Administration System (PAS) in 48 hospitals/health trusts performing hip fracture surgery in Norway. • All stays in hospital with a primary or secondary diagnosis code matching the ICD-9 code 820 (all subgroups) or the ICD-10 codes S72.0, S72.1, and S72.2 were retrieved.
    [Show full text]
  • Emergency Preparedness and Role Clarity Among Rescue Workers During the Terror Attacks in Norway July 22, 2011
    RESEARCH ARTICLE Emergency Preparedness and Role Clarity among Rescue Workers during the Terror Attacks in Norway July 22, 2011 May Janne Botha Pedersen1, Astrid Gjerland2,Bjørn Rishovd Rund3, Øivind Ekeberg4,5, Laila Skogstad5,6* 1 Departments of General Surgery, Orthopedic Surgery, Anesthesia, Emergency Care, Intensive Care, and Obstetrics, Ringerike Hospital, Vestre Viken Hospital Trust, Drammen, Norway, 2 Departments of Anesthesia, Intensive Care, and Emergency, Baerum Hospital, Vestre Viken Hospital Trust, Drammen, Norway, 3 Department of Psychology, University of Oslo and Vestre Viken Hospital Trust, Drammen, Norway, 4 Department of Behavioral Sciences in Medicine, Institute of Basic Medical Sciences, Faculty of a11111 Medicine, University of Oslo, Oslo, Norway, 5 Department of Acute Medicine, Research and Development, Oslo University Hospital, Oslo, Norway, 6 Paramedic Sciences, Oslo and Akershus University College, Oslo, Norway * [email protected]; [email protected] OPEN ACCESS Abstract Citation: Pedersen MJB, Gjerland A, Rund BR, Ekeberg Ø, Skogstad L (2016) Emergency Background Preparedness and Role Clarity among Rescue Workers during the Terror Attacks in Norway July 22, Few studies address preparedness and role clarity in rescue workers after a disaster. On 2011. PLoS ONE 11(6): e0156536. doi:10.1371/ July 22, 2011, Norway was struck by two terror attacks; 77 people were killed and many journal.pone.0156536 injured. Healthcare providers, police officers and firefighters worked under demanding con- Editor: Saravana Kumar, University of South ditions. The aims of this study were to examine the level of preparedness, exposure and Australia, AUSTRALIA role clarity. In addition, the relationship between demographic variables, preparedness and Received: August 11, 2015 exposure and a) role clarity during the rescue operations and; b) achieved mastering for Accepted: May 16, 2016 future disaster operations.
    [Show full text]
  • Innkalling Og Forslag Til Saksliste HO21-Rådsmøte 28.02
    Til HelseOmsorg21-rådet Vår saksbehandler/tlf. Vår ref. Oslo, Hilde D.G. Nielsen, +4740922260/[email protected] 19/375 18.2.2019 Innkalling til HelseOmsorg21-rådsmøte 28.2.2019 (01/19) Vedlagt følger forslag til saksliste og sakspapirer til møte i HelseOmsorg21-rådet torsdag 28.2.2019 (01/19). Tid: kl 10.00 – 15.30. Sted: Forskningsrådet, Drammensveien 288, Lysaker. Vel møtt! Med vennlig hilsen Norges forskningsråd HelseOmsorg21-sekretariatet Hilde D. G. Nielsen, sekretariatsleder/spesialrådgiver Møte i HelseOmsorg21-rådet (01/19) Dato: Torsdag 28. februar 2019, kl 10.00 – 15.30 Sted: Forskningsrådet, Lysaker, møterom Abel 1 og 2 Saksliste Kl 10.00 – 10.15 Sak 01/19 Godkjenning av saksliste Sak 02/19 Godkjent referat Sak 03/19 Orienteringer Kl 10.15 – 11.00 Sak 04/19 Kunnskapssamarbeid med Kina Kl 11.00 – 12.00 Sak 05/19 Presentasjon og behandling av rapporten Research and Innovation for Better Health Lunsj kl 12.00-12.30 Kl 12.30 – 13.30 Sak 06/19 Presentasjon og behandling av sluttrapporten fra KSF Kort pause kl 13.30 – 13.45 Kl 13.45 - 14.45 Sak 07/19 HO21-rådets egenvurdering Kort pause kl 14.45 – 15.00 Kl 15.00 – 15.30 Sak 08/19 Orientering om status for arbeidet med stortingsmelding om innovasjon i offentlig sektor Kl 15.30 Sak 09/19 Eventuelt Saksfremlegg sak 02/19 – møte 01/19 Sak 02/19 Godkjent referat Type sak: Orienteringssak Til: HO21-rådet Fra: HO21-sekretariatsleder Hilde D.G. Nielsen Vedlegg: Godkjent referat fra møte 29.11.2018 (05/18) Referent: Sekretariatsleder Hilde D.G.
    [Show full text]
  • ERJ-03448-2020.Shareable
    ORIGINAL ARTICLE | INFECTION AND LUNG FUNCTION Dyspnoea, lung function and CT findings 3 months after hospital admission for COVID-19 Tøri Vigeland Lerum1, Trond Mogens Aaløkken2,3, Eivind Brønstad4,5, Bernt Aarli6,7, Eirik Ikdahl8, Kristine Marie Aarberg Lund9, Michael T. Durheim3,10, Jezabel Rivero Rodriguez2, Carin Meltzer2, Kristian Tonby3,11, Knut Stavem 3,8,12, Ole Henning Skjønsberg1,3, Haseem Ashraf3,13,14 and Gunnar Einvik3,8,14 Affiliations: 1Dept of Pulmonary Medicine, Oslo University Hospital Ullevål, Oslo, Norway. 2Dept of Radiology and Nuclear Medicine, Oslo University Hospital Ullevål, Oslo, Norway. 3Institute for Clinical Medicine, University of Oslo, Oslo, Norway. 4Thoracic Dept, St Olavs Hospital, Trondheim, Norway. 5Dept of Circulation and Medical Imaging, Faculty of Medicine and Health Sciences NTNU, Trondheim, Norway. 6Dept of Thoracic Medicine, Haukeland University Hospital, Haukeland, Norway. 7Dept of Clinical Science, University of Bergen, Bergen, Norway. 8Pulmonary Dept, Akershus University Hospital, Lørenskog, Norway. 9Dept of Infectious Diseases, Østfold Hospital Trust Kalnes, Grålum, Norway. 10Dept of Respiratory Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway. 11Dept of Infectious Diseases, Oslo University Hospital Ullevål, Oslo, Norway. 12Health Services Research Unit, Akershus University Hospital, Lørenskog, Norway. 13Dept of Diagnostic Imaging, Akershus University Hospital, Lørenskog, Norway. 14Shared last authors. Correspondence: Gunnar Einvik, Pulmonary Dept, Akershus University Hospital, 1470 Lørenskog, Norway. E-mail [email protected] @ERSpublications 3 months after discharge, a quarter of COVID-19 survivors have reduced gas diffusion capacity and persistent parenchymal opacities. ICU treatment is associated with persistent parenchymal opacities, but not with dyspnoea or reduced diffusing capacity. https://bit.ly/2J3xH4x Cite this article as: Lerum TV, Aaløkken TM, Brønstad E, et al.
    [Show full text]